The major historical production and use of asbestos in the form of various building materials and commercial products 
have resulted in millions of people being exposed to asbestos. Mesothelioma is an asbestos-related tumour. In the disease of Mesothelioma, malignant cells develop in the mesothelium, a protective lining that covers most of the body’s internal organs. Its most common site is the pleura, but it may also occur in the peritoneum, the heart, the pericardium or tunica vaginalis.
There is a strong association between peritoneal mesothelioma and asbestos exposure. Furthermore, extensive research has been conducted to study the carcinogenic effects of asbestos fibres and their role in tumorigenesis, according to this article. Etiology, Clinical Presentation, Current Diagnosis, its Histopathology, and Current Treatment of Mesothelioma were detailed in this article.
The following article is one of the Canadian Journal of Surgery published February 2009 which described asbestos-related tumour, current understanding and the management of peritoneal mesothelioma. The authors were Terence C. Chua, BScMed and colleagues from the University of New South Wales Department of Surgery, St. George Hospital, Kogarah, New South Wales, Sydney, Australia.
Read completely about Peritoneal Mesothelioma Treatment; an Updated Surgery Journal in 6 pages of 145 KB Pdf filetype available to download (source: pubmedcentral.nih.gov). See also related section about Mesothelioma in case you’re interested.
